Oramed Pharmaceuticals - 21 Year Stock Price History | ORMP
Historical daily share price chart and data for Oramed Pharmaceuticals since 2004 adjusted for splits and dividends. The latest closing stock price for Oramed Pharmaceuticals as of November 14, 2025 is 2.33.
- The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
- The Oramed Pharmaceuticals 52-week high stock price is 3.09, which is 32.6% above the current share price.
- The Oramed Pharmaceuticals 52-week low stock price is 1.82, which is 21.9% below the current share price.
- The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.27.
| Oramed Pharmaceuticals Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 2.2580 | 2.4100 | 2.7000 | 2.0000 | 2.3300 | -3.72% |
| 2024 | 2.4935 | 2.4500 | 3.5800 | 2.0700 | 2.4200 | 4.76% |
| 2023 | 2.9146 | 12.4000 | 13.1000 | 1.7100 | 2.3100 | -80.80% |
| 2022 | 7.8654 | 13.8900 | 13.8900 | 3.7200 | 12.0300 | -15.76% |
| 2021 | 14.4812 | 4.3500 | 29.7500 | 4.2200 | 14.2800 | 236.79% |
| 2020 | 3.6137 | 4.9400 | 5.5000 | 2.4800 | 4.2400 | -17.67% |
| 2019 | 3.4802 | 3.3600 | 5.7400 | 2.4300 | 5.1500 | 71.67% |
| 2018 | 6.0685 | 9.1400 | 9.1400 | 3.0000 | 3.0000 | -66.67% |
| 2017 | 7.9929 | 6.3800 | 11.1500 | 5.8700 | 9.0000 | 47.06% |
| 2016 | 7.3860 | 8.4900 | 9.5700 | 5.7100 | 6.1200 | -28.42% |
| 2015 | 6.4028 | 5.0000 | 9.4400 | 3.7300 | 8.5500 | 87.50% |
| 2014 | 10.5659 | 18.2000 | 28.9100 | 4.4500 | 4.5600 | -70.45% |
| 2013 | 7.7059 | 4.0800 | 15.4300 | 3.8400 | 15.4300 | 289.65% |
| 2012 | 3.7605 | 3.2400 | 4.4400 | 3.1200 | 3.9600 | 17.86% |
| 2011 | 3.7292 | 4.0800 | 4.9800 | 3.0000 | 3.3600 | -6.67% |
| 2010 | 5.0515 | 4.8000 | 6.6000 | 3.4800 | 3.6000 | -33.33% |
| 2009 | 5.2433 | 4.8000 | 7.6800 | 2.5200 | 5.4000 | 15.38% |
| 2008 | 6.8316 | 3.7200 | 11.4000 | 3.0000 | 4.6800 | 50.00% |
| 2007 | 6.3764 | 11.4000 | 11.8800 | 2.5200 | 3.1200 | -69.05% |
| 2006 | 10.3436 | 6.0000 | 14.4000 | 6.0000 | 10.0800 | 170.97% |
| 2005 | 4.2600 | 6.1200 | 6.1200 | 3.6000 | 3.7200 | -69.31% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.098B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.767B | 25.90 |
| EssilorLuxottica (ESLOY) | France | $171.623B | 0.00 |
| Boston Scientific (BSX) | United States | $155.627B | 35.59 |
| Stryker (SYK) | United States | $142.805B | 28.35 |
| Medtronic (MDT) | Ireland | $123.317B | 17.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.676B | 0.00 |
| Agilent Technologies (A) | United States | $41.643B | 26.95 |
| ResMed (RMD) | United States | $36.793B | 25.47 |
| GE HealthCare Technologies (GEHC) | United States | $33.695B | 16.11 |
| Koninklijke Philips (PHG) | Netherlands | $27.848B | 18.19 |
| Insulet (PODD) | United States | $23.402B | 72.64 |
| Terumo (TRUMY) | Japan | $22.490B | 25.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.949B | 11.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.072B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.548B | 30.74 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.522B | 10.73 |
| Haemonetics (HAE) | United States | $3.460B | 15.40 |
| ICU Medical (ICUI) | United States | $3.420B | 21.71 |
| Envista Holdings (NVST) | United States | $3.270B | 18.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.885B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.034B | 40.93 |
| Perrigo (PRGO) | Ireland | $1.923B | 4.82 |
| Phibro Animal Health (PAHC) | United States | $1.812B | 18.10 |
| Curaleaf Holdings (CURLF) | Canada | $1.735B | 0.00 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.507B | 9.69 |
| Neogen (NEOG) | United States | $1.384B | 26.54 |
| Green Thumb Industries (GTBIF) | United States | $1.379B | 60.46 |
| Kestra Medical Technologies (KMTS) | United States | $1.282B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.269B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| BioLife Solutions (BLFS) | United States | $1.210B | 359.14 |
| InMode (INMD) | Israel | $0.904B | 10.21 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.794B | 0.00 |
| Surmodics (SRDX) | United States | $0.592B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.499B | 17.17 |
| Evolus (EOLS) | United States | $0.478B | 0.00 |
| CeriBell (CBLL) | United States | $0.463B | 0.00 |
| SNDL (SNDL) | Canada | $0.447B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.427B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.304B | 53.37 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.264B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.264B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 146.33 |
| Quanterix (QTRX) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 19.42 |
| Owens & Minor (OMI) | United States | $0.227B | 2.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.85 |
| Sanara MedTech (SMTI) | United States | $0.175B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.33 |
| OraSure Technologies (OSUR) | United States | $0.164B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.119B | 5.20 |
| Jushi Holdings (JUSHF) | United States | $0.106B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.27 |
| Sharps Technology (STSS) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 23.27 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.030B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.35 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Zynex (ZYXI) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |